Richard A Anderson Selected Research

Dinoprost

9/2009	Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
11/2005	A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
9/2005	A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
2/2004	Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Anderson Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 08/2002
24	Insulin Resistance 01/2021 - 12/2003
17	Breast Neoplasms (Breast Cancer) 04/2022 - 04/2007
16	Type 2 Diabetes Mellitus (MODY) 07/2013 - 08/2003
12	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 02/2008
11	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 09/2006
11	Inflammation (Inflammations) 11/2012 - 01/2006
10	Adenocarcinoma 01/2011 - 02/2004
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 12/2006
7	Infertility (Sterility) 01/2021 - 10/2014
6	Azoospermia 12/2019 - 09/2004
5	Body Weight (Weight, Body) 01/2021 - 12/2007
5	Obesity 05/2015 - 12/2003
4	Carcinogenesis 01/2020 - 02/2004
4	Primary Ovarian Insufficiency 03/2016 - 10/2010
4	Mitochondrial Diseases (Mitochondrial Disease) 10/2015 - 04/2009
3	Glioma (Gliomas) 01/2021 - 02/2014
3	Weight Gain 12/2018 - 05/2010
3	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 02/2011
3	Hemorrhage 11/2015 - 02/2014
3	Brain Edema (Cerebral Edema) 10/2015 - 06/2010
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 10/2018
2	Leukemia 11/2021 - 10/2021
2	Premature Birth (Birth, Premature) 10/2021 - 01/2021
2	Spontaneous Abortion (Miscarriage) 01/2021 - 03/2020
2	Hot Flashes 12/2020 - 01/2018
2	Leiomyoma (Uterine Fibroids) 03/2020 - 01/2014
2	Amenorrhea 01/2020 - 11/2017
2	Heart Failure 11/2019 - 03/2002
2	Ovarian Hyperstimulation Syndrome 12/2018 - 03/2012
2	Hyperprolactinemia 11/2017 - 09/2011
2	Neoplasm Metastasis (Metastasis) 10/2017 - 01/2010
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2017 - 01/2016
2	Acute Coronary Syndrome 08/2016 - 11/2015

Drug/Important Bio-Agent (IBA)

20	Insulin (Novolin)FDA Link 10/2016 - 12/2003
18	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2003
17	Hormones (Hormone)IBA 01/2022 - 02/2006
17	Proteins (Proteins, Gene)FDA Link 05/2021 - 12/2004
16	PolyphenolsIBA 03/2019 - 12/2005
11	LipidsIBA 12/2016 - 12/2003
10	Messenger RNA (mRNA)IBA 01/2013 - 09/2005
9	Testosterone (Sustanon)FDA Link 01/2022 - 09/2006
9	FructoseIBA 01/2018 - 01/2007
8	AntioxidantsIBA 01/2011 - 08/2003
7	CholesterolIBA 10/2016 - 12/2003
7	TeaIBA 10/2015 - 01/2007
7	prostaglandin F2alpha receptorIBA 01/2011 - 02/2004
7	ChromiumIBA 05/2010 - 12/2003
7	ProstaglandinsIBA 01/2010 - 12/2004
6	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2003
6	Neurokinin BIBA 01/2021 - 02/2015
6	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2020 - 01/2010
6	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 01/2010
6	EnzymesIBA 01/2016 - 09/2009
6	Cadherins (E-Cadherin)IBA 09/2012 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
5	KisspeptinsIBA 01/2021 - 01/2010
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2003
5	GonadotropinsIBA 01/2020 - 09/2004
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 09/2005
4	SteroidsIBA 01/2021 - 01/2006
4	Estrogens (Estrogen)FDA Link 01/2020 - 01/2003
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2019 - 09/2012
4	Phosphates (Orthophosphate)IBA 10/2016 - 01/2010
4	LDL CholesterolIBA 10/2016 - 12/2003
4	Lipoproteins (Lipoprotein)IBA 11/2012 - 01/2008
4	thiamine triphosphorate (TTP)IBA 03/2011 - 01/2007
4	DinoprostIBA 09/2009 - 02/2004
3	Anti-Mullerian HormoneIBA 04/2022 - 09/2011
3	Oncogene Proteins (Oncogene Protein)IBA 05/2021 - 01/2015
3	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021 - 03/2011
3	AndrogensIBA 01/2021 - 10/2011
3	AntralIBA 01/2019 - 03/2012
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2010
3	LigandsIBA 01/2016 - 12/2009
3	Pharmaceutical PreparationsIBA 10/2014 - 11/2009
3	HDL CholesterolIBA 10/2011 - 12/2003
3	CalcineurinIBA 01/2011 - 12/2009
3	Prostaglandins FIBA 12/2009 - 02/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009 - 01/2007
3	picolinic acid (chromium picolinate)IBA 04/2009 - 12/2007
3	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2009 - 06/2005
2	Neurokinin-3 ReceptorsIBA 01/2022 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 11/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2014
2	LeptinIBA 01/2021 - 01/2010
2	inhibin BIBA 01/2021 - 09/2011
2	Peptides (Polypeptides)IBA 01/2020 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2014
2	human KISS1 proteinIBA 11/2017 - 07/2013

Therapy/Procedure

29	Drug Therapy (Chemotherapy) 04/2022 - 01/2006
18	Therapeutics 01/2022 - 03/2002
7	Aftercare (After-Treatment) 01/2022 - 08/2002
6	Radiotherapy 01/2022 - 10/2011
4	Stents 08/2016 - 11/2009
3	Contraception (Birth Control) 01/2021 - 02/2015
3	Adjuvant Chemotherapy 01/2018 - 10/2010